Having shown that decreased cellular lipid content by adiponectin causes disorders of in the structures and function of lipid raft, we speculated that the alterations in lipid metabolism may contribute to the anti-breast cancer effects of adiponectin. This evidence concerns the gene ADIPOQ and breast cancer.